Work

Neoadjuvant dose-dense (DD) concurrent doxorubicin (A) and docetaxel (T) for stage III breast cancer (BC)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.10721

Authors: M. Abu-Khalaf, R. Kim, M. Cohenuram, G. Chung, M. Digiovanna, B. Haffty, D. Carter, L. Horvath, F. Tavassoli, B. Burtness

Institutions: Fox Chase Cancer Center, Yale University, Rutgers Cancer Institute

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2748526411

Cites:

Cited by:

Related to: 10